Navigation Links
Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
Date:10/13/2009

EVRY, October 13 /PRNewswire/ -- Philippe Marliere, cofounder and initiator of the project, has announced the establishment of the scientific advisory board:

    - Dr. Bernard Badet heads a research group at the Institut de
      Chimie des Substances Naturelles (Gif-sur-Yvette, France) that is
      interested in the understanding of the enzyme mechanism towards the
      development of chemical tools for diagnostic and therapeutic purposes.

    - Prof. Donald Hilvert heads a research group at the ETH
      Zurich (Zurich, Switzerland). His research program focuses on
      understanding how enzymes work and evolve and on mimicking the
      properties of these remarkable catalysts in the laboratory.

    - Prof. Jean-Marc Paris led the R&D division responsible for
      antibiotic discovery at Rhone Poulenc Rorer before joining Rhodia,
      where he worked as Scientific Director for organic chemistry and
      biotechnologies. He is honorary Professor at the Ecole Nationale
      Superieure de Chimie de Paris.

    - Prof. Dieter Soll heads a research laboratory at Yale
      University in New Haven (Connecticut, USA), investigating the
      biocatalytic and evolutionary basis of protein biosynthesis. Prof. Soll
      is a member of the US Academy of Sciences.

    - Dr. Jean Weissenbach is the Director of Genoscope, the
      French genome sequencing center, which he founded in 1997. Now part of
      the Genomics Institute of the CEA, Genoscope is searching new enzyme
      activities using genomics and large scale experimentation. Dr.
      Weissenbach is a member of the French Academy of Sciences.

Global Bioenergies, located on the Genopole campus close to Paris, has today announced the proof-of-concept of a synthetic metabolic pathway for producing isobutene, a key building block that can be converted into transportation fuels, polymers and various commodity chemicals.

Macha Anissimova, Head of Research, said "We are very proud to have reached this key milestone in advance on schedule. We have benefited from the assistance of Genoscope and of the analytical chemistry platform of Evry-Val d'Essonne University. The bioproduction of a gaseous hydrocarbon will make it possible to obtain pure products at high yield and low cost.".

According to Prof. Dieter Soll, "The data on isobutene formation presented by Global Bioenergies are convincing, and I am now impatient to see the process optimized and scaled up."

"Development of such an artificial metabolic pathway represents a signal accomplishment with enormous implications. Standard technologies for enzyme and metabolic engineering can now be applied to transform this proof of concept into a viable industrial process," added Prof. Donald Hilvert.

Marc Delcourt, cofounder and CEO of the company concludes: "We are now focusing on industrializing the process, which will be financed through a second round currently in preparation."

Please visit our new web site: http://www.global-bioenergies.com

SOURCE Global Bioenergies


'/>"/>
SOURCE Global Bioenergies
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
2. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
3. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
4. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
5. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
6. Global Biofuels Growth to Double by 2015
7. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
8. Global Public Health the Focus of Scientific Conference
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
11. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
Breaking Biology News(10 mins):